Results 211 to 220 of about 2,202,582 (329)
Molecular determinants of signal transduction in tropomyosin receptor kinases
Tropomyosin receptor kinases control critical neuronal functions, but how do the same receptors produce diverse cellular responses? This review explores the structural mechanisms behind Trk signaling diversity, focusing on allosteric modulation and ligand bias.
Giray Enkavi
wiley +1 more source
Drug interaction (17. combination with hyperlipidemia) [PDF]
Kawasaki, Yoichi +2 more
core +2 more sources
Utility of physiologically based pharmacokinetic modeling in predicting and characterizing clinical drug interactions [PDF]
R. Foti
openalex +1 more source
Skin biopsies taken from a patient with an ultra‐rare disorder as well as controls were cultured for up to 473 days. The chunks of skin were serially transferred to a new culture plate when confluent with fibroblasts. Different generations of fibroblasts were analyzed for cell and molecular properties, proliferation, and competence for reprogramming to
Sudiksha Rathan‐Kumar +3 more
wiley +1 more source
Research on drug-drug interaction prediction using capsule neural network based on self-attention mechanism. [PDF]
Chen X, Wang Z, Miao Z, Nie B.
europepmc +1 more source
Amsacrine as a Topoisomerase II Poison: Importance of Drug–DNA Interactions
Adam C. Ketron +3 more
openalex +2 more sources
Day/night variations of myeloid and lymphoid cell subsets in the murine inguinal lymph node
The circadian system is involved in the temporal regulation of the immune system. Our study reveals that two innate immune populations, NKT cells and neutrophils, predominate at the beginning of the day in healthy mice, highlighting how the time of day influences immune responses.
Paula M. Wagner +6 more
wiley +1 more source
PS3N: leveraging protein sequence-structure similarity for novel drug-drug interaction discovery. [PDF]
Islam S +5 more
europepmc +1 more source
The relationship between anabolic and catabolic processes governing lung cancer cell growth is nuanced. We show that ATG4B, an autophagy regulator, is elevated in lung cancer and that high ATG4B is associated with worse patient outcomes. Targeting ATG4B in cells reduces growth, protein synthesis, and mTORC1 activity, demonstrating a new relationship ...
Patrick J. Ryan +6 more
wiley +1 more source

